Tag: Parkinson’s
Natural Environments May Cut Hospitalization for Patients With Neurodegenerative Diseases
Normalized difference vegetation index negatively associated with hospitalization for Alzheimer disease and related dementia, Parkinson disease
Deferiprone Not Beneficial for Newly Diagnosed Parkinson Disease
Greater decrease seen in nigrostriatal iron content with deferiprone, but more patients have symptom progression leading to initiation of dopaminergic therapy
Parkinsonism, Parkinson Disease Risk Up With Bilateral Oophorectomy Before 43
Risk increased in premenopausal women undergoing oophorectomy for benign indication before age 43 years
ENT-01 Safe, Improves Constipation in Patients With Parkinson Disease
Improvement seen in weekly complete spontaneous bowel movement rate and in secondary end points
Weight Loss in Early Parkinson Linked to Cognitive Decline
Patients with weight loss in first year have significantly faster decline in Montreal Cognitive Assessment scores
Hospital-Treated Infections Earlier in Life Tied to Alzheimer, Parkinson Disease Risk
Association found for Alzheimer and Parkinson disease cases diagnosed before 60 years of age
Monoclonal Antibodies No Better Than Placebo for Early Parkinson Disease
Two studies show lack of benefit in primary or secondary end points with cinpanemab or prasinezumab versus placebo
Genetic Mutations May Help Predict Survival in Parkinson Disease
Among patients with Parkinson disease, SNCA or GBA mutations associated with shorter survival compared with no mutations
Risk for Parkinson Disease Reduced After Myocardial Infarction
During median follow-up of 21 years, risk reduced for Parkinson disease, secondary parkinsonism after MI
Flavonoid Intake Linked to Mortality Risk in Parkinson Disease
Higher flavonoid intake after diagnosis of Parkinson disease linked to reduced risk for all-cause mortality
